Sign up to our newsletter

If you want more information on this opportunity or if you are an inventor, a university tech transfer office, a VC or indeed you just want to be part of our innovation community, we would love to talk with you.

Contact Us

Medlab Group

 

Medlab Group, is a young Australian biotechnology company, specialising in out-licencing and consultancy in human life sciences. The company has a portfolio of patented drug delivery platforms and a dynamic team of individuals with a proven track record for product innovation, clinical trials, patent development, and translational research. The company services markets inĀ  APAC, Europe, and North America. Medlab Group is actively looking for commercial partners in the Pharma, Nutraceutical, Food & Beverage and Personal Care sectors to out-license their patented technology.

Dr Sean Hall is the Founder & Managing Director of Medlab Group, which was spun out of Medlab Clinical in 2023, together with the patented drug delivery platforms. Sean has worked extensively in the human life sciences sector, with over 20 years experience in nutraceutical sales and development, as well as early drug discovery in Australia, Asia and the US. Sean has led and inspired his teams to author multiple patents, write peer reviewed articles and deliver lectures at global scientific conferences. His passion is leading his researchers into novel areas and strong commercialisation opportunities.

Whilst at Medlab Clinical, Sean led the research and development of the patented drug delivery platform NanoCelleĀ®. The NanoCelleĀ® drug delivery platform offers the ability to overcome the limitations of current drug delivery platforms by enhancing drug absorption, leading to:

  • Greater bioavailability;
  • Rapid onset of action;
  • And reduced risk of side effects.

So how does NanoCelleĀ® achieve this? As the name suggests, NanoCelleĀ® is a nano cell technology, with the NanoCelleĀ® particles (the drug delivery mechanism) 200 times smaller than red blood cells. Each NanoCelleĀ® nanoparticle has a nanoscopic fat-soluble core surrounded by a water-soluble outer layer. This structure enables the NanoCelleĀ® to maintain high concentrations of selected actives, and to deliver nano-particle-sized drug formulations for absorption across the oro-buccal mucosa. The is the mucous membrane lining the inside of the mouth.

Just to put the enhanced bioavailability into perspective ā€“ typically a drug/active that is orally ingested (via tablet/capsule) would take 45-90 minutes to have an effect and bioavailability would be about 5%. Using the NanoCelleĀ® drug delivery platform, the drug/active can be delivered via the oro-buccal mucosa, taking 3-5 minutes to have an effect with bioavailability of 30% plus.

Here’s a short video explaining how the NanoCelleĀ® technology works:

 

 

Medlab Group have initially focussed on the pharma and nutraceutical markets, however the NanoCelleĀ® technology platform is very relevant to other industry sectors where the platform can be used as an ā€œencapsulationā€ technology. For example, it could be used within food & beverages to encapsulate actives or other additives, oral care products (throat gargles and toothpaste) to encapsulate actives, cosmetics and personal care (again as a delivery mechanism for actives), etc.

The Medlab Group product portfolio offers differentiation and uniqueness with market-ready and near-market-ready products, accompanied by a strong scientific and clinical team allowing for product variations, clinical trials, enhanced development, and market access support.

Medlab group are actively looking for commercial partners in the Pharma, Food & Beverage and Personal Car sectors to utilise the Medlab technology to improve product performance.Ā  Medlab Group are open to discussing different commercial models including white labelling, technology licensing and other commercial arrangements.

If you are interested in partnering with Medlab Group or would just like further information, in the first instance, please reach out to John Allies, email: john@strategicallies.co.uk.

Ā 

Images courtesy of Medlab Group Pty Ltd